Matching slides 13,983
Current window 7,411-7,440
Pages 467
Rows per page 30
Loop: 11 Golden Circleclear collectionreset all

Loop

7,411-7,440 of 13,983

filter-aware
20
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities (mRNA, CAR-T, Antibodies, Small Molecules, Engineered Biologicals) contribute to two main strategic pillars: Targeting Cancer and Immunomodulation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
The slide uses a timeline-like visual representation for clinical phases.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
22
The slide uses a combination of a conceptual process diagram and flow cytometry data plots to validate the mechanism of action.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a combination of quantitative metrics and qualitative clinical context to establish the problem.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
24
Includes a citation to a Nature publication and a visual representation of the mRNA construct.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
25
Clinical trial design diagram showing randomization of 120 patients into three arms.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
26
The slide uses a geographic map to illustrate disease prevalence and a table to highlight low ORR and mOS for existing therapies.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
27
The slide uses a diagram to illustrate the mRNA structure of BNT113 encoding HPV-E6 and HPV-E7.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
28
Includes patient-level response table, pie chart of response types, and visual ELISPOT assay results for patients 6 and 7.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
29
Clinical trial design diagram showing Part A (safety run-in) and Part B (randomization).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
30
The diagram uses a process flow structure to show patient progression from surgery through screening to treatment allocation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
Includes a visual comparison of PK profiles (recombinant vs RiboCytokine) and a pipeline table for BNT151 and BNT152+153.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
32
Slide 32 of a presentation, likely BioNTech R&D day.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
33
The slide uses a three-column layout to categorize trial updates, phase 2 starts, and phase 1 starts.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
34
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
35
The table shows a significant increase in commercial revenues and operating profit compared to the prior year.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
36
The chart uses a stacked bar format to decompose revenue into four categories, with a specific focus on COVID-19 vaccine revenue.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
37
The slide uses a structured layout with three distinct sections for revenue, expenses, and tax.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
38
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
39
The slide uses a hub-and-spoke diagram to categorize therapeutic modalities. Bottom text highlights a specific recent transaction (Kite).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
40
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
41
Slide 41 from a BioNTech presentation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
42
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
04
Celsius Holdings | ESG Presentation Deck | 16 slidesCelsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Loop · Golden Circle1 hit
05
Includes an infographic on the right side highlighting aluminum industry recycling statistics.Celsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
Celsius Holdings | ESG Presentation Deck | 16 slidesCelsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
07
Includes corporate background, product ingredients/certifications, and a call to action for the 'Live Fit' lifestyle.Celsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
08
The slide uses a 'No' callout to emphasize the absence of negative ingredients, a common marketing tactic for health-conscious products.Celsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
09
The slide emphasizes scientific validation to build consumer trust.Celsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
10
The slide serves as a credibility-building appendix page.Celsius Holdings | ESG Presentation Deck | 16 slides · Celsius Holdings
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit